The growth stack contains:

CJC1295 – 5MG
Ipamorelin – 10mg

Product Overview

The Growth Stack is a dual-peptide research combination pairing CJC-1295 (no DAC) with Ipamorelin. This blend is designed for laboratory investigation into pituitary gland secretagogue synergy, pulsatile growth hormone (GH) output, and downstream insulin-like growth factor 1 (IGF-1) endocrine signaling.

Components: CJC-1295 (no DAC) / Ipamorelin
Quantity: 5 mg (CJC-1295) / 10 mg (Ipamorelin)
Physical Form: Lyophilized powder
Purity Standard: Greater than 99% (HPLC / Mass Spectrometry verified)
Primary Application: In vitro and animal model research on anterior pituitary receptor crosstalk and somatotrope regulation

Mechanistic Profile in Research

Dual-Receptor Pituitary Synergy: CJC-1295 acts

on the GHRH receptor while Ipamorelin selectively targets the GHS-R1a (ghrelin) receptor. Co-administration produces a synergistic, rather than additive, release of growth hormone from somatotropes.
Pulsatile Release Preservation: Because CJC-1295 (no DAC) has a short half-life matching Ipamorelin’s kinetic profile, the combination induces a clean, physiological pulse of GH without continuous, non-pulsatile receptor desensitization.
Selective Endocrine Action: Ipamorelin maintains receptor selectivity, allowing researchers to study elevated GH/IGF-1 axis dynamics without significant off-target cortisol, prolactin, or ACTH spikes.
Metabolic & Anabolic Signaling: In research models, the downstream elevation of circulating IGF-1 supports studies on protein synthesis, nitrogen retention, lipid mobilization, and

connective tissue recovery.

Handling and Storage Protocol

Reconstitution: Dilute using sterile Bacteriostatic Water (0.9% Benzyl Alcohol). Direct the diluent slowly against the inner glass wall of the vial and gently swirl until dissolved. Avoid rapid agitation.
Lyophilized Form: Store at -20 degrees C for long-term preservation; shield from light exposure.
Reconstituted State: Keep refrigerated at 2 degrees C to 8 degrees C and use within 28 days to maintain compound stability. Avoid repeated freeze-thaw cycles.

This product is provided strictly for laboratory research and analytical testing by qualified scientific professionals. It is not approved for human or veterinary administration, diagnostic protocols, or therapeutic applications.